| P50 | author | Kensuke Sakamoto | Q87784781 |
| P2093 | author name string | James J Crowley | |
| P2860 | cites work | Predicting effective microRNA target sites in mammalian mRNAs | Q21128766 |
| | Biology of adeno-associated viral vectors in the central nervous system | Q21129328 |
| | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 |
| | Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS | Q21563317 |
| | Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 |
| | An integrated encyclopedia of DNA elements in the human genome | Q22122150 |
| | The evolution and functional diversification of animal microRNA genes | Q22122309 |
| | Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium | Q23747506 |
| | TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing | Q24306121 |
| | The Microprocessor complex mediates the genesis of microRNAs | Q24312976 |
| | Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 |
| | Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder | Q24594904 |
| | Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis | Q24597718 |
| | MicroRNA-mediated non-cell-autonomous regulation of cortical radial glial transformation revealed by a Dicer1 knockout mouse model | Q48348306 |
| | A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity | Q48348498 |
| | Profile of microRNA expression in brain tumors of different malignancy | Q48473937 |
| | Circulating microRNA-137 is a potential biomarker for human glioblastoma | Q48502936 |
| | Impact of the genome-wide schizophrenia risk single nucleotide polymorphism (rs1625579) in miR-137 on brain structures in healthy individuals | Q48930309 |
| | Stereologic investigation of the posterior part of the hippocampus in schizophrenia | Q48934263 |
| | Hemizygous deletions on chromosome 1p21.3 involving the DPYD gene in individuals with autism spectrum disorder. | Q50301287 |
| | Circulating miRNA biomarkers for schizophrenia? | Q50554743 |
| | Quantitative genetic modeling of variation in human brain morphology. | Q52414983 |
| | microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. | Q53059683 |
| | Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades. | Q55461278 |
| | Role for Rapid Dendritic Protein Synthesis in Hippocampal mGluR-Dependent Long-Term Depression | Q60141744 |
| | Molecular biology. miRNAs in neurodegeneration | Q80970561 |
| | MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer | Q84360710 |
| | Resequencing and association analysis of MIR137 with schizophrenia in a Japanese population | Q86818679 |
| | Identifying gene regulatory networks in schizophrenia | Q24601410 |
| | MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 |
| | Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis | Q24631440 |
| | A mammalian microRNA expression atlas based on small RNA library sequencing | Q24644709 |
| | An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP | Q24645518 |
| | The microRNA.org resource: targets and expression | Q24650094 |
| | microRNA modulation of circadian-clock period and entrainment | Q24652558 |
| | Processing of intronic microRNAs | Q24677011 |
| | MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms | Q24680714 |
| | Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein | Q24810079 |
| | Neuron-Glia Interactions in Neural Plasticity: Contributions of Neural Extracellular Matrix and Perineuronal Nets | Q26765730 |
| | Tuning the cell fate of neurons and glia by microRNAs | Q26852077 |
| | Dendritic spine pathology in schizophrenia | Q26991935 |
| | The schizophrenia risk gene product miR-137 alters presynaptic plasticity. | Q27312392 |
| | Astrocytes: biology and pathology | Q27490746 |
| | Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans | Q27860584 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 |
| | Identification of tissue-specific microRNAs from mouse | Q27860892 |
| | Identification of novel genes coding for small expressed RNAs | Q27860917 |
| | Processing of primary microRNAs by the Microprocessor complex | Q27860986 |
| | Biogenesis of small RNAs in animals | Q27861013 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers | Q28080153 |
| | Obesity-associated variants within FTO form long-range functional connections with IRX3 | Q28236283 |
| | Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex | Q28243956 |
| | Genome-wide association study identifies five new schizophrenia loci | Q28248384 |
| | Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA | Q28256854 |
| | miR-137 inhibits proliferation of melanoma cells by targeting PAK2 | Q28265238 |
| | Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database | Q28285397 |
| | Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 |
| | The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease | Q28305485 |
| | Chromatin crosstalk in development and disease: lessons from REST | Q28306534 |
| | Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia | Q35014711 |
| | MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck | Q35051089 |
| | How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association | Q35065388 |
| | Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults | Q35090701 |
| | Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells | Q35148549 |
| | miRDB: an online resource for microRNA target prediction and functional annotations | Q35253629 |
| | Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137. | Q35369598 |
| | Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia risk | Q35489742 |
| | Understanding the role of dicer in astrocyte development | Q35592589 |
| | Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation | Q35596962 |
| | Neurological disease: listening to gene silencers. | Q35679362 |
| | MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. | Q35691087 |
| | miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells | Q35818683 |
| | Two New Cases of 1p21.3 Deletions and an Unbalanced Translocation t(8;12) among Individuals with Syndromic Obesity. | Q35905457 |
| | MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia | Q35940904 |
| | Biochemical mechanisms for translational regulation in synaptic plasticity | Q35954296 |
| | Effect of propofol on microRNA expression in rat primary embryonic neural stem cells | Q36163067 |
| | Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder | Q36323567 |
| | Neurodevelopmental model of schizophrenia: update 2012 | Q36417310 |
| | Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci | Q36493030 |
| | Schizophrenia genetic variants are not associated with intelligence | Q36551460 |
| | Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia | Q36915423 |
| | A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression | Q36994815 |
| | The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila | Q37019346 |
| | Dicer is required for neural stem cell multipotency and lineage progression during cerebral cortex development. | Q37079314 |
| | Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex | Q37120426 |
| | Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers | Q37159843 |
| | MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients | Q37363559 |
| | Gene expression elucidates functional impact of polygenic risk for schizophrenia | Q37372402 |
| | Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia | Q37407215 |
| | Progress in microRNA delivery | Q37478933 |
| | Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells | Q37505070 |
| | Tobacco smoking and methylation of genes related to lung cancer development | Q37644809 |
| | Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells | Q37706529 |
| | Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus | Q34165822 |
| | Ontogeny of small RNA in the regulation of mammalian brain development | Q34227170 |
| | MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells | Q34314172 |
| | Glial cell abnormalities in major psychiatric disorders: the evidence and implications | Q34384584 |
| | A reference methylome database and analysis pipeline to facilitate integrative and comparative epigenomics | Q34390926 |
| | The many faces of REST oversee epigenetic programming of neuronal genes | Q34449364 |
| | Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans | Q34475541 |
| | MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome | Q34554942 |
| | No effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure | Q34578760 |
| | MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives | Q34599354 |
| | Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia | Q34603780 |
| | MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. | Q34606028 |
| | From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment | Q34632695 |
| | A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder | Q34657883 |
| | Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs | Q34738450 |
| | MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines | Q34757887 |
| | Distribution of miRNA expression across human tissues | Q39964196 |
| | Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer | Q39996295 |
| | Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. | Q40026960 |
| | MicroRNA-137 represses Klf4 and Tbx3 during differentiation of mouse embryonic stem cells. | Q40140967 |
| | CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector | Q40643280 |
| | Genome-wide association study of schizophrenia in Ashkenazi Jews. | Q40710686 |
| | The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia. | Q41002359 |
| | Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. | Q41135067 |
| | MIR137 is the key gene mediator of the syndromic obesity phenotype of patients with 1p21.3 microdeletions | Q41660743 |
| | Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study | Q41818539 |
| | MicroRNA-124 and -137 cooperativity controls caspase-3 activity through BCL2L13 in hippocampal neural stem cells | Q42014794 |
| | miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche | Q42243673 |
| | Disruption of the microRNA 137 primary transcript results in early embryonic lethality in mice. | Q42260728 |
| | MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors | Q42484700 |
| | Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq | Q42776227 |
| | An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling | Q42920996 |
| | Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. | Q43143033 |
| | Differential regulation of schizophrenia-associated microRNA gene function by variable number tandem repeats (VNTR) polymorphism | Q43185270 |
| | Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. | Q43496188 |
| | Genome-wide schizophrenia variant at MIR137 does not impact white matter microstructure in healthy participants | Q43515220 |
| | Internalization of ionotropic glutamate receptors in response to mGluR activation | Q43785653 |
| | The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals | Q43898671 |
| | Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia | Q45008149 |
| | Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | Q45263643 |
| | Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease | Q45290680 |
| | Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders | Q46461905 |
| | Effects of MIR137 on fronto-amygdala functional connectivity | Q46690026 |
| | Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression | Q47973594 |
| | MicroRNA-137 Controls AMPA-Receptor-Mediated Transmission and mGluR-Dependent LTD. | Q48118147 |
| | The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia | Q48140110 |
| | Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder | Q37725363 |
| | Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues | Q37738471 |
| | MicroRNAs and glial cell development | Q37873693 |
| | Developing microRNA therapeutics | Q37981141 |
| | MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction | Q37992401 |
| | Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins. | Q38062443 |
| | Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model | Q38066632 |
| | White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies | Q38073848 |
| | miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. | Q38138933 |
| | Dopaminergic basis of salience dysregulation in psychosis | Q38175606 |
| | The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders | Q38176151 |
| | Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy | Q38221828 |
| | microRNAs as novel biomarkers of schizophrenia (Review) | Q38265172 |
| | Circulating microRNA biomarker studies: pitfalls and potential solutions | Q38267750 |
| | Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model | Q38291113 |
| | Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability | Q38331099 |
| | miR-124, -128, and -137 Orchestrate Neural Differentiation by Acting on Overlapping Gene Sets Containing a Highly Connected Transcription Factor Network. | Q38457838 |
| | DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review | Q38584010 |
| | Controlling transcription in human pluripotent stem cells using CRISPR-effectors. | Q38622601 |
| | Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus. | Q38751829 |
| | Circulating microRNAs as a Novel Class of Potential Diagnostic Biomarkers in Neuropsychiatric Disorders | Q38834809 |
| | Next stop for the CRISPR revolution: RNA-guided epigenetic regulators | Q38850026 |
| | MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies. | Q38928442 |
| | MiR-137: an important player in neural development and neoplastic transformation. | Q38952716 |
| | Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse | Q38973671 |
| | Transcriptional targets of the schizophrenia risk gene MIR137. | Q38979078 |
| | MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets | Q38989183 |
| | The interplay between neurons and glia in synapse development and plasticity. | Q38992784 |
| | MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls | Q39002120 |
| | OTTO: a new strategy to extract mental disease-relevant combinations of GWAS hits from individuals | Q39127096 |
| | Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer | Q39234989 |
| | miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. | Q39239384 |
| | miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. | Q39382240 |
| | miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. | Q39609457 |
| | Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression | Q39793664 |
| | Epigenetic regulation of microRNA expression in colorectal cancer | Q39838959 |
| | MicroRNAs are essential for development and function of inner ear hair cells in vertebrates | Q28509271 |
| | Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132 | Q28510360 |
| | A MicroRNA feedback circuit in midbrain dopamine neurons | Q28513149 |
| | A molecular timescale for vertebrate evolution | Q29547791 |
| | Research domain criteria (RDoC): toward a new classification framework for research on mental disorders | Q29547877 |
| | HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants | Q29614906 |
| | Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 |
| | Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 |
| | Animal models of neuropsychiatric disorders | Q29619899 |
| | miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells | Q30176408 |
| | Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways | Q30405346 |
| | Potential Impact of miR-137 and Its Targets in Schizophrenia | Q30454963 |
| | ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data | Q30577864 |
| | Developmental suppression of schizophrenia-associated miR-137 alters sensorimotor function in zebrafish. | Q30824416 |
| | Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology | Q30982690 |
| | Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia | Q32000373 |
| | The neurodevelopmental theory of schizophrenia: evidence from studies of early onset cases | Q33670034 |
| | REST maintains self-renewal and pluripotency of embryonic stem cells | Q33694355 |
| | Different timings of Dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system | Q33701894 |
| | The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. | Q33722837 |
| | Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse | Q33732656 |
| | Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory | Q33760611 |
| | Specific glial functions contribute to schizophrenia susceptibility | Q33762530 |
| | Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 |
| | Convergence of genes and cellular pathways dysregulated in autism spectrum disorders | Q33794546 |
| | The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects | Q33923604 |
| | Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. | Q33924728 |
| | Transcriptional landscape of the prenatal human brain | Q33926910 |
| | Transcriptome-wide discovery of microRNA binding sites in human brain. | Q33940022 |
| | Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome | Q33989539 |
| | Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins | Q34105857 |
| | miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells | Q34115743 |
| | Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis | Q34125617 |
| | miRNA expression profiling of lung adenocarcinomas: correlation with mutational status | Q34136203 |
| | Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. | Q34148217 |
| P433 | issue | 2 | |
| P921 | main subject | microRNA | Q310899 |
| | schizophrenia | Q41112 |
| P304 | page(s) | 242-256 | |
| P577 | publication date | 2017-06-14 | |
| P1433 | published in | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | Q15762380 |
| P1476 | title | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia | |
| P478 | volume | 177 | |